Northwestern Mutual Investment Management Company’s Ionis Pharmaceuticals IONS Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-14,132	Closed	-$875K	–	965
2015 Q4	$875K	Buy	14,132 +42	+0.3%	+$2.27K	0.02%	392
2015 Q3	$570K	Hold	14,090	–	–	0.01%	506
2015 Q2	$811K	Buy	+14,090	New	+$896K	0.02%	451

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northwestern Mutual Investment Management Company's IONS Position: Q1 2016 in Review

Northwestern Mutual Investment Management Company sold out of Ionis Pharmaceuticals (IONS) in Q1 2016, closing a stake of 14,132 shares — an estimated $875K sold.

Northwestern Mutual Investment Management Company first reported a position in IONS in Q2 2015 and held it in 3 quarters. The position peaked at $875K in Q4 2015. 315 funds tracked by Wall St. Rank hold IONS as of Q1 2016.

Northwestern Mutual Investment Management Company reported no remaining Ionis Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Northwestern Mutual Investment Management Company sold 14,132 Ionis Pharmaceuticals shares in Q1 2016, an estimated $875K.
Northwestern Mutual Investment Management Company first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 3 quarters.
Northwestern Mutual Investment Management Company's Ionis Pharmaceuticals position peaked at $875K in Q4 2015.
315 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2016.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q1 2016, filed 16 May 2016.